P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS

P-58 CONCORDANCE BETWEEN ECOGRAPHY AND THE CONTINUOUS ATTENUATION PARAMETER (CAP) BY TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS OF LIVER STEATOSIS

Introduction: Abdominal ultrasound is the test of choice for the screening of liver steatosis (LS) however it has a poor performance (20%). Transient elastography (TE) through the Continuous Attenuation Parameter (CAP) has shown an adequate correlation with the degree of steatosis by liver biopsy. O...

Full description

Bibliographic Details
Main Authors:	Juan Francisco Rozas, Katherine González, Camila Estay, Maximo Cattaneo, Alvaro Urzúa, Juan Pablo Roblero, Alexandra Sandoval, Jaime Poniachik
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268121001216

Similar Items

P-65 CONCORDANCE OF FIB-4 WITH TRANSITION ELASTOGRAPHY IN THE DIAGNOSIS OF ADVANCED LIVER FIBROSIS
by: Juan Francisco Rozas, et al.
Published: (2021-09-01)

P-67 ULTRASOUND GUIDED TRANSIENT ELASTOGRAPHY FOR THE DIAGNOSIS AND STAGING OF LIVER FIBROSIS
by: Juan Francisco Rozas, et al.
Published: (2021-09-01)

Transient Elastography and Controlled Attenuation Parameter (CAP) in the Assessment of Liver Steatosis in Severe Adult Growth Hormone Deficiency
by: Adriana Claudia Lopes Carvalho-Furtado, et al.
Published: (2019-06-01)

Écographies. Écologies et littératures pour la jeunesse
by: Javier De Agustín
Published: (2018-07-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

P-126 INTERPHASE HEPATITIS IN PRIMARY BILIARY CHOLANGITIS, SEVERITY FACTOR AND NO RESPONSE TO URSODEOXICOLIC ACID?
by: Felipe Ramírez, et al.
Published: (2021-09-01)

P-62 INFECTIONS IN THE FIRST MONTH POST LIVER TRANSPLANTATION IN A TRANSPLANT CENTER IN CHILE
by: Gabriel Uribe, et al.
Published: (2021-09-01)

P-57 LIVER STEATOSIS AND STEATOHEPATITIS IN LIVER DISEASES OTHER THAN ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER
by: Ana Jiménez, et al.
Published: (2021-09-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population
by: Hirsh D. Trivedi, et al.
Published: (2021-09-01)

The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19
by: Isabel Campos-Varela, et al.
Published: (2021-05-01)

P-59 LIVER TRANSPLANTATION: SIX YEARS EXPERIENCE IN A UNIVERSITY HOSPITAL OF CHILE
by: Hiru Chang, et al.
Published: (2021-09-01)

P-44 TRANSARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH CONTROVERSIAL INDICATION
by: Alejandra Domínguez, et al.
Published: (2021-09-01)

P-40 SEVERE AUTOIMMUNE HEPATITIS: CORTICOSTEROID THERAPY OR EARLY ENROLLMENT TO LIVER TRANSPLANTATION
by: Andrea Jiménez, et al.
Published: (2021-09-01)

Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
by: Nicolas Lanthier, et al.
Published: (2021-01-01)

Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals
by: Yvelise Ferro, et al.
Published: (2017-09-01)

Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan®)
by: Chi-Cervera Luis Alberto, et al.
Published: (2021-01-01)

P-64 THE ALCOHOL-ASSOCIATED LIVER DISEASE PARADOX IN CHILE: AN ASSESSMENT WITH DATA FROM THE NATIONAL HEALTH SURVEY (ENS 2016-2017)
by: Gianfranco Oneto, et al.
Published: (2021-09-01)

Assessment of hepatic fibrosis and steatosis by vibration-controlled transient elastography and controlled attenuation parameter versus non-invasive assessment scores in patients with non-alcoholic fatty liver disease
by: Ahmed M. F. Mansour, et al.
Published: (2020-09-01)

P-61 LIVER TRANSPLANTATION IN HEPATOCARCINOMA: SURVIVAL AND RECURRENCE IN TRANSPLANTED PATIENTS WITH HEPATOCARCINOMA
by: Daniela García, et al.
Published: (2021-09-01)

P-38 UTILITY OF PUPILLARY REACTIVITY IN THE FUNCTIONAL ASSESSMENT OF THE AUTONOMOUS NERVOUS SYSTEM IN PATIENTS WITH CHRONIC LIVER DISEASE: PRELIMINARY RESULTS
by: Christian Lara, et al.
Published: (2021-09-01)

Publisher Correction: Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
by: Nicolas Lanthier, et al.
Published: (2021-03-01)

Clinical applications of transient elastography
by: Kyu Sik Jung, et al.
Published: (2012-06-01)

Assessment of ultrasound elastography to grade hepatic steatosis in a rat model
by: TANG Shaoshan
Published: (2013-04-01)

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.
by: Thierry Poynard, et al.
Published: (2016-01-01)

Association Between Transient Elastography and Controlled Attenuated Parameter and Liver Ultrasound in Children With Cystic Fibrosis
by: Wen Ye, et al.
Published: (2021-08-01)

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography
by: Kanittha Ratchatasettakul, et al.
Published: (2017-04-01)

Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience
by: Ioan Sporea, et al.
Published: (2020-04-01)

P-39 EXPERIENCE IN THE MANAGEMENT OF REFRACTORY HEPATIC ENCEPHALOPATHY THROUGH ENDOVASCULAR THERAPY
by: Claudia Muñoz, et al.
Published: (2021-09-01)

P-43 INDICATORS OF RESPONSE TO FIRST TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELULLAR CARCINOMA
by: Alejandra Domínguez, et al.
Published: (2021-09-01)

Concordance and characterization of massively parallel sequencing at 58 STRs in a Tibetan population
by: Hui Li, et al.
Published: (2021-04-01)

Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.
by: Kyu Sik Jung, et al.
Published: (2014-01-01)

Why is transient elastography essential in hepatology?
by: Misael Uribe-Ramos;, et al.
Published: (2009-04-01)

The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis
by: Jong Ho Chung, et al.
Published: (2013-06-01)

Correction: Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
by: The Staff
Published: (2014-01-01)

Correction: Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease.
Published: (2014-01-01)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
by: Katarzyna Kozłowska-Petriczko, et al.
Published: (2021-04-01)

An ultrasound transient elastography system with coded excitation
by: Xianfen Diao, et al.
Published: (2017-06-01)

What is to be done when transient elastography is not feasible?
by: Raluca Lupusoru, et al.
Published: (2016-12-01)

Prevalence in vulnerable population of liver fibrosis identified by transient elastography
by: Norberto Chávez-Tapia, et al.
Published: (2015-07-01)